Phase II
A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension
- Study HIC#:2000035353
- Last Updated:03/25/2024
This is a research study that aims to evaluate the effectiveness of sirolimus in individuals with pulmonary hypertension.
- Age18 years and older
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Anna Hessler
- Phone Number: 1-203-506-3907
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
This is a research study that aims to evaluate the effectiveness of sirolimus in individuals with pulmonary hypertension.
Eligibility Criteria
Individuals aged 18+ diagnosed with pulmonary hypertension
